BackApplied Genetic Technologies Overview

Applied Genetic Technologies Receivables

Track Applied Genetic Technologies's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

Applied Genetic Technologies Receivables History

Loading

Applied Genetic Technologies vs. peers: Receivables Comparison

Loading

Applied Genetic Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Applied Genetic Technologies (AGTC) FAQ

As of the most recent data (September 2022), AGTC shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AGTC's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Applied Genetic Technologies is outperforming or lagging.

Tracking AGTC's receivables over time shows whether Applied Genetic Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Applied Genetic Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Applied Genetic Technologies's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.